Michael S. Levine

Michael S. Levine's AcademicInfluence.com Rankings

Michael S. Levine

Biology

#11361

World Rank

#14751

Historical Rank

Neuroscience

#1836

World Rank

#1892

Historical Rank

biology Degrees

Download Badge

Biology

Michael S. Levine's Degrees

PhD Neuroscience Stanford University

Why Is Michael S. Levine Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael S. Levine's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* (2003) (843)
Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice (2008) (577)
Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. (1993) (573)
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein (2004) (386)
Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease (1999) (373)
Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum (1998) (363)
Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: A critical review and the UCLA experience (2009) (363)
Heterosynaptic Dopamine Neurotransmission Selects Sets of Corticostriatal Terminals (2004) (363)
Transient and Progressive Electrophysiological Alterations in the Corticostriatal Pathway in a Mouse Model of Huntington's Disease (2003) (353)
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. (2001) (317)
The corticostriatal pathway in Huntington's disease (2007) (304)
Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. (1998) (297)
NMDA receptor function in mouse models of Huntington disease (2001) (293)
Changes in Cortical and Striatal Neurons Predict Behavioral and Electrophysiological Abnormalities in a Transgenic Murine Model of Huntington's Disease (2001) (287)
Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32. (2002) (285)
Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function (2011) (275)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. (2004) (262)
Are neostriatal dopamine receptors co-localized? (1993) (240)
Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. (2001) (209)
Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice (2008) (204)
Epileptogenesis in pediatric cortical dysplasia: The dysmature cerebral developmental hypothesis (2006) (188)
Differential electrophysiological properties of dopamine D1 and D2 receptor‐containing striatal medium‐sized spiny neurons (2008) (184)
Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia (2003) (183)
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect (2004) (179)
Differential modulation by dopamine of responses evoked by excitatory amino acids in human cortex (1992) (175)
Modulatory Actions of Dopamine on NMDA Receptor-Mediated Responses Are Reduced in D1A-Deficient Mutant Mice (1996) (169)
GABAergic basal forebrain neurons project to the neocortex: The localization of glutamic acid decarboxylase and choline acetyltransferase in feline corticopetal neurons (1988) (164)
Dopamine and Glutamate in Huntington's Disease: A Balancing Act (2010) (158)
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease (2009) (157)
Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease (2014) (156)
Neurofibromin regulates corticostriatal inhibitory networks during working memory performance (2010) (148)
Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease (2009) (144)
Excitatory synaptic transmission in neostriatal neurons: regulation by cyclic AMP-dependent mechanisms (1995) (142)
Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synuclein (2011) (139)
Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility (2013) (138)
Dopamine D4 Receptor-Deficient Mice Display Cortical Hyperexcitability (2001) (136)
Where Do You Think You Are Going? The NMDA-D1 Receptor Trap (2006) (134)
Multiple effects of serotonin on membrane properties of trigeminal motoneurons in vitro. (1997) (133)
Dye‐Coupling in the neostriatum of the rat: I. Modulation by dopamine‐depleting lesions (1989) (130)
Increased GABAergic function in mouse models of Huntington's disease: Reversal by BDNF (2004) (129)
Differential Susceptibility to Excitotoxic Stress in YAC128 Mouse Models of Huntington Disease between Initiation and Progression of Disease (2009) (128)
Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease (2007) (126)
Differential Electrophysiological Changes in Striatal Output Neurons in Huntington's Disease (2011) (124)
Basolateral Amygdala to Orbitofrontal Cortex Projections Enable Cue-Triggered Reward Expectations (2017) (123)
Neuromodulatory actions of dopamine on synaptically‐evoked neostriatal responses in slices (1996) (119)
Neuromodulatory actions of dopamine on synaptically‐evoked neostriatal responses in slices (1996) (118)
Targeted Expression of Mu-Opioid Receptors in a Subset of Striatal Direct-Pathway Neurons Restores Opiate Reward (2014) (114)
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing (2005) (113)
Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease (2012) (105)
The spontaneous firing pattern of forebrain neurons. I. The effects of dopamine and non-dopamine depleting lesions on caudate unit firing patterns. (1974) (104)
Multiple Sources of Striatal Inhibition Are Differentially Affected in Huntington's Disease Mouse Models (2013) (103)
Contralateral hemimicrencephaly and clinical-pathological correlations in children with hemimegalencephaly. (2006) (102)
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein (2006) (100)
Alterations in N‐methyl‐D‐aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease (2005) (98)
Striatal neurochemical changes in transgenic models of Huntington's disease (2002) (98)
Striatal potassium channel dysfunction in Huntington's disease transgenic mice. (2005) (98)
Effects of caudate nuclei or frontal cortical ablations in kittens: Neurology and gross behavior (1976) (97)
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids (2010) (95)
Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein (2009) (94)
Are Cytomegalic Neurons and Balloon Cells Generators of Epileptic Activity in Pediatric Cortical Dysplasia? (2005) (94)
Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons (2015) (92)
A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington’s disease in mice (2013) (92)
Repeated Exposure to Methamphetamine Causes Long-Lasting Presynaptic Corticostriatal Depression that Is Renormalized with Drug Readministration (2008) (92)
Action sequencing is impaired in D1A‐deficient mutant mice (1998) (90)
Neurofilament-M Interacts with the D1 Dopamine Receptor to Regulate Cell Surface Expression and Desensitization (2002) (90)
NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue. (2004) (89)
Pallidal and entopeduncular intracellular responses to striatal, cortical, thalamic, and sensory inputs. (1974) (87)
Persistent Na+ conductance in medium-sized neostriatal neurons: characterization using infrared videomicroscopy and whole cell patch-clamp recordings. (1995) (87)
Effects of repeated amphetamine treatment on the locomotor activity of the dopamine D1A‐deficient mouse (1997) (85)
Pediatric Cortical Dysplasia: Correlations between Neuroimaging, Electrophysiology and Location of Cytomegalic Neurons and Balloon Cells and Glutamate/GABA Synaptic Circuits (2005) (85)
Genetic mouse models of Huntington’s disease: focus on electrophysiological mechanisms (2010) (82)
Immature Neurons and GABA Networks May Contribute to Epileptogenesis in Pediatric Cortical Dysplasia (2007) (82)
Sensorimotor dysfunctions and aphagia and adipsia following pallidal lesions in rats. (1971) (82)
Modulation of AMPA currents by D2 dopamine receptors in striatal medium‐sized spiny neurons: are dendrites necessary? (2004) (81)
Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease (2010) (79)
The role of dopamine in Huntington's disease. (2014) (77)
Parvalbumin Interneurons Modulate Striatal Output and Enhance Performance during Associative Learning (2017) (76)
CREB controls cortical circuit plasticity and functional recovery after stroke (2018) (73)
Cytomegalic Interneurons: A New Abnormal Cell Type in Severe Pediatric Cortical Dysplasia (2007) (73)
Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease. (2006) (73)
The mouse cortico–basal ganglia–thalamic network (2020) (72)
Sensorimotor functions of the striatopallidal system and lateral hypothalamus and consummatory behavior in rats. (1973) (71)
Neurons Recorded from Pediatric Epilepsy Surgery Patients with Cortical Dysplasia (2000) (70)
Functional and molecular development of striatal fast‐spiking GABAergic interneurons and their cortical inputs (2005) (70)
Postnatal Development of Glutamate Receptor-Mediated Responses in the Neostriatum (1998) (70)
Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease (2011) (69)
Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease. (2015) (68)
Reorganization of Pericruciate cortical projections to the spinal cord and dorsal column nuclei after neonatal or adult cerebral hemispherectomy in cats (1986) (66)
Alpha‐synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway (2009) (64)
D2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera (1993) (64)
The GABAergic striatonigral neurons of the cat: demonstration by double peroxidase labeling (1986) (64)
Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice (2015) (63)
A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease. (2012) (63)
Human cortical dysplasia and epilepsy: an ontogenetic hypothesis based on volumetric MRI and NeuN neuronal density and size measurements. (2004) (63)
Basic Mechanisms of Epileptogenesis in Pediatric Cortical Dysplasia (2015) (63)
Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice (2017) (61)
Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons (2012) (60)
Dye‐Coupling in the neostriatum of the rat: II. Decreased coupling between neurons during development (1989) (60)
Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits (1997) (60)
Hippocampal units during orienting and arousal in rabbits. (1974) (58)
Dissecting the Contribution of Individual Receptor Subunits to the Enhancement of N-methyl-d-Aspartate Currents by Dopamine D1 Receptor Activation in Striatum (2011) (57)
Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model (2018) (57)
Parvalbumin Interneurons Modulate Striatal Output and Enhance Performance during Associative Learning (2018) (55)
Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons (1998) (53)
Metabotropic glutamate receptors modulateN-methyl-d-aspartate receptor function in neostriatal neurons (1994) (53)
Dye-Coupling in the Neostriatum of the Rat (1991) (51)
Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease. (2012) (48)
Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex (2012) (48)
Interhemispheric organization of corticocaudate projections in the cat: A retrograde double-labelling study (1984) (48)
Electrophysiological and Morphological Analyses of Cortical Neurons Obtained from Children with Catastrophic Epilepsy: Dopamine Receptor Modulation of Glutamatergic Responses (1999) (47)
Neurophysiological, pharmacological and morphological properties of human caudate neurons recorded in vitro (1994) (47)
Retrograde effects of amygdaloid stimulation on conditioned suppression (CER) in rats. (1970) (46)
Intracellular analysis of the development of responses of caudate neurons to stimulation of cortex, thalamus and substantia nigra in the kitten (1979) (46)
Quantitative developmental studies of feline neostriatal spiny neurons. (1981) (46)
Sensory, motor and cognitive alterations in aged cats (1987) (46)
D2 dopamine receptor protein location: Golgi impregnation‐gold toned and ultrastructural analysis of the rat neostriatum (1994) (45)
Aging reduces neostriatal responsiveness toN-methyl-d-aspartate and dopamine: anIn vitro electrophysiological study (1996) (45)
Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice. (2007) (43)
Quantitative morphology of medium-sized caudate spiny neurons in aged cats (1986) (43)
Development and serotonergic modulation of NMDA bursting in rat trigeminal motoneurons. (2002) (42)
Enhanced GABAergic Inputs Contribute to Functional Alterations of Cholinergic Interneurons in the R6/2 Mouse Model of Huntington’s Disease,, (2015) (42)
Changes in Expression of N-Methyl-D-Aspartate Receptor Subunits Occur Early in the R6/2 Mouse Model of Huntington’s Disease (2006) (41)
Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia (2014) (41)
Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II (2010) (39)
Development of motor activity in kittens. (1980) (39)
Differential sensitivity of medium‐ and large‐sized striatal neurons to NMDA but not kainate receptor activation in the rat (2001) (38)
Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease (2017) (37)
Recovery of functions after neonatal or adult hemispherectomy in cats. III. Complex functions: Open field exploration, social interactions, maze and holeboard performances (1986) (37)
Interneurons, GABA currents, and subunit composition of the GABAA receptor in type I and type II cortical dysplasia (2010) (37)
Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines (2010) (37)
Neurophysiological maturation of cat caudate neurons: Evidence from in vitro studies (1991) (37)
A neurophysiological analysis of the development of cortico-caudate connections in the cat (1976) (36)
Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R 6 / 2 Huntington ’ s Disease Transgenic Mice (2001) (36)
Branched projections of pallidal and peripallidal neurons to neocortex and neostriatum: a double-labeling study in the cat (1985) (36)
Dopamine modulation of responses mediated by excitatory amino acids in the neostriatum. (1998) (35)
Regulation of N-methyl-D-aspartate-induced toxicity in the neostriatum: a role for metabotropic glutamate receptors? (1996) (35)
Intracellular neurophysiological analysis reveals alterations in excitation in striatal neurons in aged rats (1989) (35)
Striatal Ionotropic Glutamate Receptor Ontogeny in the Rat (2000) (34)
Calcium modulates dopamine potentiation of N‐methyl‐D‐aspartate Responses: Electrophysiological and imaging evidence (2004) (34)
Glutamate receptor-induced toxicity in neostriatal cells (1996) (33)
Physiological and morphological characterization of striatal neurons transplanted into the striatum of adult rats (1988) (33)
Transmitter cosynthesis by corticopetal basal forebrain neurons (1989) (33)
Agonist‐induced morphologic decrease in cellular d1A dopamine receptor staining (1997) (33)
Postnatal development of caudate input neurons in the cat (1983) (33)
Neuronal Targets of Mutant Huntingtin Genetic Reduction to Ameliorate Huntington’s Disease Pathogenesis in Mice (2014) (32)
NMDA and Dopamine: Diverse Mechanisms Applied to Interacting Receptor Systems (2009) (32)
Ultrastructural alterations in caudate nucleus in aged cats (1988) (32)
Metabotropic glutamate receptor modulation of excitotoxicity in the neostriatum: role of calcium channels (1999) (32)
Neuronal coupling via connexin36 contributes to spontaneous synaptic currents of striatal medium‐sized spiny neurons (2008) (32)
Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease (2012) (31)
Development of the kitten substantia nigra: a rapid Golgi study of the early postnatal period. (1983) (31)
Postnatal development of identified medium-sized caudate spiny neurons in the cat. (1986) (30)
Dual-component excitatory amino acid-mediated responses in trigeminal motoneurons and their modulation by serotonin in vitro. (1996) (30)
Location, Location, Location: Contrasting Roles of Synaptic and Extrasynaptic NMDA Receptors in Huntington's Disease (2010) (30)
Long-term decreases in spontaneous firing of caudate neurons induced by amphetamine in cats (1980) (30)
Endogenous opioids mediate basal hedonic tone independent of dopamine d-1 or d-2 receptor activation (2004) (29)
JAKMIP1, a Novel Regulator of Neuronal Translation, Modulates Synaptic Function and Autistic-like Behaviors in Mouse (2015) (29)
Effects of caudate nuclei or frontal cortical ablations in kittens: Motor activity and visual discrimination performance in neonatal and juvenile kittens (1978) (29)
In Rasmussen Encephalitis, Hemichannels Associated with Microglial Activation are linked to Cortical Pyramidal Neuron Coupling: A Possible Mechanism for Cellular Hyperexcitability (2015) (29)
Dopaminergic function in the neostriatum and nucleus accumbens of young and aged fischer 344 rats (1997) (28)
The spontaneous firing patterns of forebrain neurons. III. Prevention of induced asymmetries in caudate neuronal firing rates by unilateral thalamic lesions (1977) (28)
Development of striatal fast-spiking GABAergic interneurons. (2007) (28)
NEOSTRIATAL DOPAMINE RECEPTORS. REPLY (1994) (28)
Cortical Damage Enhances Pemoline-Induced Self-Injurious Behavior in Prepubertal Rats (1999) (28)
Basal forebrain neurons have axon collaterals that project to widely divergent cortical areas in the cat (1986) (27)
Neurophysiological alterations in caudate neurons in aged cats (1987) (27)
Dye-coupling in human neocortical tissue resected from children with intractable epilepsy. (1993) (27)
Reactivity to saccharin and guinine solutions following amygdaloid or septal lesions in rats. (1972) (27)
Branched projections of cat sensorimotor cortex: multiple retrograde labeling via commissural corticocortical, decussated corticostriatal and undecussated corticostriatal axons (1986) (27)
Development of spontaneous neuronal activity in the caudate nucleus, globus pallidus-entopeduncular nucleus, and substantia nigra of the cat. (1982) (27)
The spontaneous firing patterns of forebrain neurons. II. Effects of unilateral caudate nuclear ablation. (1974) (26)
Delayed Postnatal Development of NMDA Receptor Function in Medium-Sized Neurons of the Rat Striatum (2001) (26)
Pyramidal cell responses to γ‐aminobutyric acid differ in type I and type II cortical dysplasia (2008) (26)
Behavioral reactivity and visual evoked potentials to photic stimuli following septal lesions in rats. (1972) (26)
Age-induced changes in electrophysiological responses of neostriatal neurons recorded in vitro (1992) (26)
Postnatal ontogeny of evoked neuronal responses in the substantia nigra of the cat. (1982) (26)
Frontal cortical synaptic communication is abnormal in Disc1 genetic mouse models of schizophrenia (2013) (25)
The morphogenesis of glutamic acid decarboxylase in the neostriatum of the cat: neuronal and ultrastructural localization. (1987) (25)
Opioid self-administration results in cell-type specific adaptations of striatal medium spiny neurons (2013) (25)
Norepinephrine modulates excitatory amino acid-induced responses in developing human and adult rat cerebral cortex (1994) (25)
Effects of amphetamine on intracellular responses of caudate neurons in the cat (1984) (24)
Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function (2011) (24)
Axonal branching of basal forebrain projections to the neocortex: a double-labeling study in the cat (1986) (23)
Kynurenic acid antagonizes the excitatory postsynaptic potential elicited in neostriatal neurons in the in vitro slice of the rat (1989) (23)
Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease (2018) (23)
Neurophysiological maturation of cat substantia nigra neurons: Evidence from in vitro studies (1991) (23)
Decreased GluR2(B) receptor subunit mRNA expression in cerebellar neurons at risk for degeneration. (1993) (23)
Iontophoretic application of NMDA produces different types of excitatory responses in developing human cortical and caudate neurons (1991) (23)
Neurons of origin of striatonigral axons in the cat: connectivity and Golgi markers of somatodendritic architecture (1986) (22)
Subcortical crossed axonal projections to the caudate nucleus of the cat: A double-labelling study (1984) (21)
A Hypothesis Regarding the Pathogenesis and Epileptogenesis of Pediatric Cortical Dysplasia and Hemimegalencephaly Based on MRI Cerebral Volumes and NeuN Cortical Cell Densities (2007) (21)
Synaptic Dysfunction in Huntington’s Disease: Lessons from Genetic Animal Models (2020) (20)
Development of somatosensory responsiveness in the basal ganglia in awake cats. (1985) (20)
Aging reduces somatosensory responsiveness of caudate neurons in the awake cat (1987) (20)
The spontaneous firing patterns of forebrain neurons. IV. Effects of bilateral and unilateral frontal cortical ablations on firing of caudate, globus pallidus and thalamic neurons (1979) (20)
A bidirectional corticoamygdala circuit for the encoding and retrieval of detailed reward memories (2021) (20)
Development of responses of globus pallidus and entopeduncular nucleus neurons to stimulation of the caudate nucleus and precruciate cortex (1979) (19)
Neurophysiological and Morphological Alterations in Caudate Neurons in Aged Cats a (1988) (19)
Pemoline alters dopamine modulation of synaptic responses of neostriatal neurons in vitro. (1997) (19)
Altered excitatory amino acid function and morphology of the cerebellum of the spastic Han-Wistar rat. (1991) (18)
Organization of developing precruciate corticostriate projections in kittens (1980) (18)
Metabotropic glutamate receptor activation selectively limits excitotoxic damage in the intact neostriatum (1996) (18)
Dopamine — Glutamate Interactions (2002) (18)
Major Contribution of Somatostatin-Expressing Interneurons and Cannabinoid Receptors to Increased GABA Synaptic Activity in the Striatum of Huntington’s Disease Mice (2019) (18)
Enhanced responses to NMDA receptor activation in the developing cat caudate nucleus (1991) (18)
Altered membrane properties and firing patterns of external globus pallidus neurons in the R6/2 mouse model of Huntington's disease (2016) (18)
Drug-primed reinstatement of cocaine seeking in mice: increased excitability of medium-sized spiny neurons in the nucleus accumbens (2013) (18)
Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease (2018) (17)
Retrograde amnestic effects of inferotemporal and amygdaloid seizures upon conditioned suppression of lever-pressing in monkeys. (1970) (17)
Gain Modulation by Corticostriatal and Thalamostriatal Input Signals during Reward-Conditioned Behavior (2019) (16)
Partial Amelioration of Peripheral and Central Symptoms of Huntington's Disease via Modulation of Lipid Metabolism. (2016) (16)
Dopamine-NMDA Receptor Interactions: Twenty Years Later (2012) (16)
Patterns of tachykinin expression and localization in developing feline neostriatum (1990) (16)
Dopamine Reduction of GABA Currents in Striatal Medium-sized Spiny Neurons is Mediated Principally by the D1 Receptor Subtype (2007) (16)
Sex-Specific Life Course Changes in the Neuro-Metabolic Phenotype of Glut3 Null Heterozygous Mice: Ketogenic Diet Ameliorates Electroencephalographic Seizures and Improves Sociability (2017) (15)
Physiological and morphological analyses of ventral anterior and ventral lateral thalamic neurons in the cat (1986) (15)
Huntington’s Disease: Neurodegeneration (2009) (15)
Age-dependent biphasic changes in ischemic sensitivity in the striatum of Huntington's disease R6/2 transgenic mice. (2005) (15)
Decortication decreases paired-pulse facilitation in the neostriatal slice of the rat (1995) (15)
The spontaneous firing patterns of forebrain neurons. V. Time course of changes in caudate unit activity following dopamine-depleting lesions (1980) (15)
Electrophysiological alterations in subthalamic neurons after unilateral dopamine depletion in the rat (2005) (14)
Neural Deletion of Glucose Transporter Isoform 3 Creates Distinct Postnatal and Adult Neurobehavioral Phenotypes (2018) (14)
Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington’s Disease Mice (2014) (14)
Striatal Excitatory Amino Acid Receptor Subunit Expression in the D1A-Dopamine Receptor-Deficient Mouse (1998) (14)
Cortical Network Dynamics Is Altered in Mouse Models of Huntington's Disease. (2019) (14)
An autoradiographic study of the postnatal development of pericruciate cortical projections to the neostriatum and the claustrum of the cat. (1986) (13)
Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington’s Disease: Are They Fit-for-Purpose for Treatment Development? (2017) (13)
Activation, Proliferation and Commitment of Endogenous Stem/Progenitor Cells to the Oligodendrocyte Lineage by TS1 in a Rat Model of Dysmyelination (2006) (13)
Metabotropic Glutamate Receptors mGluR1α and mGluR2/3 Display Dynamic Expression Patterns in Developing Rat Striatum (2001) (12)
Altered lactate metabolism in Huntington's disease is dependent on GLUT3 expression (2018) (12)
Effects of caudate nuclear or frontal cortical ablation in neonatal kittens or adult cats on the spontaneous firing of forebrain neurons. (1982) (12)
Effects of the Pimelic Diphenylamide Histone Deacetylase Inhibitor HDACi 4b on the R6/2 and N171-82Q Mouse Models of Huntington’s Disease (2013) (12)
Histamine modulates NMDA-dependent swelling in the neostriatum (1997) (12)
Evidence for Enhanced Synaptic Excitation in Transplanted Neostriatal Neurons (1993) (11)
Tonic and phasic effects evoked concurrently by sensory stimuli in hippocampal units. (1974) (11)
Ionotropic Glutamate Receptor Expression and Dopaminergic Modulation in the Developing Subthalamic Nucleus of the Rat: An Immunohistochemical and Electrophysiological Analysis (2003) (11)
Therapeutic effects of stem cells in rodent models of Huntington's disease: Review and electrophysiological findings (2018) (11)
Early postnatal development of basolateral amygdala in kitten: A golgi morphometric analysis (1985) (11)
Caudate neuronal responses evoked by cortical stimulation: contribution of an indirect corticothalamic pathway (1979) (10)
Neocortical damage alters synaptic responses of neostriatal neurons in vitro (1996) (10)
White Matter Loss in a Mouse Model of Periventricular Leukomalacia Is Rescued by Trophic Factors (2013) (9)
Postnatal differentiation and growth of cat entopeduncular neurons. A transient spiny period associated with branch elongation. (1986) (9)
Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway (2021) (8)
Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non–mTOR‐mediated etiologies (2018) (8)
Neurophysiological and anatomical interrelationships of the basal ganglia. (1975) (7)
Effects of neonatal destruction of the medial forebrain bundle in the cat: Long-term neurochemical, locomotor, and regulatory deficits (1983) (7)
Paroxysmal Discharges in Tissue Slices From Pediatric Epilepsy Surgery Patients: Critical Role of GABAB Receptors in the Generation of Ictal Activity (2020) (7)
Early postnatal development of entopeduncular neurons and their neostriatal connections (1980) (7)
Amphetamine alters evoked responses of nigral neurons in kittens and adult cats (1982) (7)
2B or Not 2B: A Tail of Two NMDA Receptor Subunits (2012) (7)
Potassium channel blockade does not alter the modulatory effects of dopamine in neostriatal slices (1996) (7)
Basal ganglionic neuronal activity and behavioral set. (1979) (7)
The entopeduncular nucleus: Golgi morphometrics of serially reconstructed neurons in adult cats (1986) (6)
Behavioral effects of phencyclidine in the developing cat (1981) (6)
Behavioral effects of phencyclidine and some of its metabolites in developing cats (1986) (6)
Epilepsy in Other Neurodegenerative Disorders: Huntington’s and Parkinson’s Diseases (2017) (6)
Acetylcholine receptor activation enhances NMDA-mediated responses in the rat neostriatum (1999) (6)
Mutations in CalDAG-GEFI Lead to Striatal Signaling Deficits and Psychomotor Symptoms in Multiple Species Including Human (2019) (6)
Alterations in Corticostriatal Synaptic Function in Huntington's and Parkinson's Diseases (2010) (6)
Evidence from the R6/2 Mouse Model of Huntington's Disease for Using Abnormal Brain Metabolism as a Biomarker for Evaluating Therapeutic Approaches for Treatment. (2012) (5)
Altered responsiveness of caudate neurons to amino acids and dopamine in aged cats (1991) (5)
Cognitive Deficits in Huntington’s Disease: Insights from Animal Models (2012) (5)
Caudate neurons respond to excitatory and inhibitory amino acids in early postnatal periods in the cat. (1990) (5)
The spastic han-wistar rat: a genetic model of amino acid-induced excitotoxicity (1992) (5)
Hippocampal electrical activity during hypothalamic-evoked consummatory behavior in rats (1970) (4)
Effects of neonatal destruction of the medial forebrain bundle in the cat: Long-term disturbances in learning ability, response to amphetamine challenge, and reactivity to auditory stimuli (1983) (4)
Dopamine and Glutamate in Huntington’s Disease (2005) (4)
Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington’s disease (2018) (4)
Abnormal brain metabolism as a biomarker for evaluating therapeutic approaches in Huntington’s disease (2012) (3)
Enhanced Epileptogenic Susceptibility in a Genetic Model of Reactive Synaptogenesis: The Spastic Han-Wistar Rat (2002) (3)
46 Epileptogenesis and Cortical Dysplasias (2010) (3)
Neurophysiological Assessment of Huntington's Disease Model Mice. (2018) (3)
Calcium Dysregulation and Compensation in Cortical Pyramidal Neurons of the R6/2 Mouse Model of Huntington's Disease. (2021) (3)
Rasmussen encephalitis tissue transfer program (2016) (2)
Behavioral effects of D-amphetamine in developing cats. (1985) (2)
Effects of intracerebroventricular L-DOPA on caudate unit firing (1977) (2)
Effects of amygdaloid lesions upon FR performance in rats. (1974) (2)
Dysfunctional channels are making noise in CAG triplet repeat disorders (2006) (2)
Thalamocortical Projections Are Significantly Impaired in the R6/2 Mouse Model of Huntington’s Disease (2022) (2)
Early impairment of thalamocortical circuit activity and coherence in a mouse model of Huntington's disease (2021) (2)
Mechanisms underlying the enhancement of γ‐aminobutyric acid responses in the external globus pallidus of R6/2 Huntington’s disease model mice (2020) (2)
NEUROPHYSIOLOGIC REGULATION OF THE BASAL GANGLIA (1978) (2)
Dopamine Receptor Modulation of Glutamatergic Neurotransmission (2010) (1)
Calcium imaging: A versatile tool to examine Huntington’s disease mechanisms and progression (2022) (1)
Author response: Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons (2015) (1)
Adult glut3 homozygous null mice survive to demonstrate neural excitability and altered neurobehavioral responses reminiscent of neurodevelopmental disorders (2021) (1)
PHYSIOLOGICAL AND MORPHOLOGICAL ANALYSES OF DEVELOPING BASAL GANGLIA (1981) (1)
Alterations of Synaptic Function in Huntington's Disease (2017) (1)
Drug-primed reinstatement of cocaine seeking in mice: increased excitability of mediumsized spiny neurons in the nucleus accumbens (2013) (1)
Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease (2012) (1)
A parametric study of the behavioral effects of phencyclidine in adult cats (1985) (1)
D2 Dopamine Receptor-Deficient Mutant Mice (2002) (0)
Optogenetic Control of Parvalbumin-Expressing Interneurons in the R6/2 Mouse Model of Huntington’s disease” (2013) (0)
Subject Index Vol. 19, 1997 (1997) (0)
Neurophysiological Changes in Aged Striatal Neurons in Rats (1991) (0)
CREB controls cortical circuit plasticity and functional recovery after stroke (2018) (0)
Subject Index Vol. 25, 2003 (2004) (0)
Electrophysiological Analysis of Movement Disorders in Mice (2011) (0)
Synaptic Alterations in Genetic Mouse Models of Huntington’s and Parkinson’s Diseases: Is there a Common Thread? (2005) (0)
Subject Index Vol. 12, 1990 (1990) (0)
Contents page + Editorial Board (2004) (0)
Contents Vol. 12, 1990 (1990) (0)
L16 Identifying a therapeutic regimen for cholesterol delivery to huntington’s disease brain (2016) (0)
Intracellular analysis of effects of phencyclidine on rat neostriatal neurons recorded in vitro (1990) (0)
Dissociable effects of oxycodone on behavior, calcium transient activity, and excitability of dorsolateral striatal neurons (2022) (0)
Dopamine Receptor-Deficient Mice 2 Striatum of D Facilitated Glutamatergic Transmission in the (2015) (0)
Huntington's Disease Transgenic Mice Striatal Potassium Channel Dysfunction in (2006) (0)
Author response for "Mechanisms underlying the enhancement of γ‐aminobutyric acid responses in the external globus pallidus of R6/2 Huntington’s disease model mice" (2020) (0)
L15 LOCAL STRIATAL EXPRESSION OF THE CHOLESTEROL DEGRADATION ENZYME, CYP46A1, IN ZQ175 MICE: BEHAVIOURAL AND NEUROPATHOLOGICAL EVALUATION (2016) (0)
756 Cellular and Network Mechanisms of Epileptogenesis in Cortical Dysplasia: A Combined Clinical, Pathological, and Electrophysiological Study (2004) (0)
Book Review:Electrical Stimulation Research Techniques. Michael M. Patterson, Raymond P. Kesner (1982) (0)
Contents Vol. 28, 2006 (2006) (0)
INTERACTIONS OF DOPAMINE (DA) AND ACETYLCHOLINE (ACh) IN THE CAUDATE NUCLEUS OF THE DEVELOPING KITTEN (1979) (0)
O.026 Mice over-expressing wild-type human alpha-synuclein as tools for therapeutic discovery in Parkinson's disease (2009) (0)
Subject Index Vol. 28, 2006 (2006) (0)
Contents Vol. 25, 2003 (2004) (0)
Title : Patterning of the Ciona intestinalis Motor Ganglion (2011) (0)
Neurophysiological Development of Fetal Neostriatal Neurons Transplanted into Adult Neostriatum (1991) (0)
Micein Dopamine Transporter Knock-Down Altered Corticostriatal Neurotransmission and (2015) (0)
Cholesterol nanoparticles partially rescue the alterations in synaptic phenotype of the R6/2 mouse model of Huntington's Disease (2012) (0)
DEVELOPMENT/MALFORMATIONS | Morphological and Electrophysiological Properties of Abnormal Cells in Pediatric Cortical Dysplasia Tissue (2009) (0)
Reply (1994) (0)
Human Neural Stem Cells Differentiate and Integrate, Innervating Implanted zQ175 Huntington’s Disease Mouse Striatum (2021) (0)
Aberrant Cells and Synaptic Circuits in Pediatric Epilepsy Surgery Patients (2008) (0)
Glutamate and Dopamine in the Developing and Adult Neostriatum (1998) (0)
Evidence for Neuronal Dysfunction in a Mouse Model of Early Stages of Huntington’s Disease (2002) (0)
Tachistoscopic thresholds following three kinds of paired-associate learning (1967) (0)
Contents Vol. 19, 1997 (1997) (0)
Central processing of sensory input leading to motor output: E.V. Evarts (Editor). (MIT Press, 1976, 72p., $2.95) (1977) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael S. Levine?

Michael S. Levine is affiliated with the following schools:

University of California, Los Angeles
Stanford University
University of California, San Francisco
University of Rochester